Hematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationTransplantation, AutologousTransplantation ConditioningGraft vs Host DiseaseBone Marrow TransplantationHematopoietic Stem Cell MobilizationHematologic NeoplasmsStem CellsBone MarrowHematopoietic Stem CellsGranulocyte Colony-Stimulating FactorBone Marrow CellsLeukapheresisTransplantation ChimeraBusulfanTreatment OutcomeAntigens, CD34Tissue DonorsGraft SurvivalMyeloablative AgonistsCombined Modality TherapyMultiple MyelomaRecurrenceMelphalanRemission InductionBlood Component RemovalCyclophosphamideVidarabineGraft vs Leukemia EffectCord Blood Stem Cell TransplantationHistocompatibility TestingLeukemiaAntineoplastic Combined Chemotherapy ProtocolsGraft vs Tumor EffectWhole-Body IrradiationLeukemia, Myeloid, AcuteImmunosuppressive AgentsRetrospective StudiesHistocompatibilityDisease-Free SurvivalSalvage TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte TransfusionSurvival RateSurvival AnalysisCytomegalovirus InfectionsMyelodysplastic SyndromesLymphocyte DepletionLymphoma, Non-HodgkinTime FactorsSiblingsNeoplasm, ResidualPrecursor Cell Lymphoblastic Leukemia-LymphomaHematopoiesisAnemia, AplasticEtoposideEmbryonic Stem CellsBlood CellsBone and BonesT-LymphocytesAntilymphocyte SerumCytarabineMesenchymal Stem Cell TransplantationAdult Stem CellsBlood Cell CountCell DifferentiationHematologic DiseasesBone Marrow DiseasesFlow CytometryBone Marrow PurgingHodgkin DiseaseAcute DiseaseInfectionFollow-Up StudiesMinor Histocompatibility AntigensAntineoplastic Agents, AlkylatingTransplantation, IsogeneicThiotepaVirus ActivationHLA AntigensCells, CulturedChimerismLiver TransplantationImmunophenotypingCytomegalovirusBlood DonorsLeukemia, MyeloidPrognosisLymphomaCell SeparationAntineoplastic AgentsHepatic Veno-Occlusive DiseaseImmunosuppressionTransplantation ImmunologyVincristinePluripotent Stem CellsLeukocyte Transfusion